BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32966279)

  • 1. Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.
    Jang AY; Kim BG; Kwon S; Seo J; Kim HK; Chang HJ; Chang SA; Cho GY; Rhee SJ; Jung HO; Kim KH; Seo HS; Kim KH; Shin J; Lee JS; Kim M; Lee YJ; Chung WJ
    PLoS One; 2020; 15(9):e0238698. PubMed ID: 32966279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
    Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
    Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
    Kabata H; Satoh T; Kataoka M; Tamura Y; Ono T; Yamamoto M; Huqun ; Hagiwara K; Fukuda K; Betsuyaku T; Asano K
    Respirology; 2013 Oct; 18(7):1076-82. PubMed ID: 23675998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in pulmonary arterial hypertension patients with BMPR2 mutation: a meta-analysis.
    Ge X; Zhu T; Zhang X; Liu Y; Wang Y; Zhang W
    Respir Res; 2020 Feb; 21(1):44. PubMed ID: 32028950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.
    Girerd B; Montani D; Eyries M; Yaici A; Sztrymf B; Coulet F; Sitbon O; Simonneau G; Soubrier F; Humbert M
    Respir Res; 2010 Jun; 11(1):73. PubMed ID: 20534176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
    Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
    Liu D; Wu WH; Mao YM; Yuan P; Zhang R; Ju FL; Jing ZC
    Circ Cardiovasc Genet; 2012 Oct; 5(5):511-8. PubMed ID: 22923421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
    Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
    Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
    Wang MT; Weng KP; Chang SK; Huang WC; Chen LW
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
    Evans JD; Girerd B; Montani D; Wang XJ; Galiè N; Austin ED; Elliott G; Asano K; Grünig E; Yan Y; Jing ZC; Manes A; Palazzini M; Wheeler LA; Nakayama I; Satoh T; Eichstaedt C; Hinderhofer K; Wolf M; Rosenzweig EB; Chung WK; Soubrier F; Simonneau G; Sitbon O; Gräf S; Kaptoge S; Di Angelantonio E; Humbert M; Morrell NW
    Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.
    Zeng Q; Yang H; Liu B; Ma Y; Liu Z; Chen Q; Li W; Luo Q; Zhao Z; Zhou Z; Xiong C
    BMC Pulm Med; 2020 May; 20(1):150. PubMed ID: 32471403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
    Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
    PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.
    Austin ED; Phillips JA; Cogan JD; Hamid R; Yu C; Stanton KC; Phillips CA; Wheeler LA; Robbins IM; Newman JH; Loyd JE
    Respir Res; 2009 Sep; 10(1):87. PubMed ID: 19785764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analyses in a cohort of 191 pulmonary arterial hypertension patients.
    Yang H; Zeng Q; Ma Y; Liu B; Chen Q; Li W; Xiong C; Zhou Z
    Respir Res; 2018 May; 19(1):87. PubMed ID: 29743074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
    Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
    Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.
    Zhu N; Gonzaga-Jauregui C; Welch CL; Ma L; Qi H; King AK; Krishnan U; Rosenzweig EB; Ivy DD; Austin ED; Hamid R; Nichols WC; Pauciulo MW; Lutz KA; Sawle A; Reid JG; Overton JD; Baras A; Dewey F; Shen Y; Chung WK
    Circ Genom Precis Med; 2018 Apr; 11(4):e001887. PubMed ID: 29631995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
    Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
    J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Features in
    Zhao Q; Zhang R; Shi J; Xie H; Zhang L; Li F; Jiang R; Wu W; Luo C; Qiu H; Li H; He J; Yuan P; Liu J; Gong S; Wang L
    Radiology; 2023 Jun; 307(5):e222488. PubMed ID: 37191488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease.
    Ulrich S; Szamalek-Hoegel J; Hersberger M; Fischler M; Garcia JS; Huber LC; Grünig E; Janssen B; Speich R
    Respiration; 2010; 79(4):279-87. PubMed ID: 19844076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.